| Issue |
BIO Web Conf.
Volume 75, 2023
The 5th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2023)
|
|
|---|---|---|
| Article Number | 05018 | |
| Number of page(s) | 15 | |
| Section | Big Data for Public Health Policy | |
| DOI | https://doi.org/10.1051/bioconf/20237505018 | |
| Published online | 15 November 2023 | |
The Economic Evaluation of HPV Vaccination as a Prevention of Non-Cervical Cancer Using Modelling Approaches: A Systematic Review
1 Faculty of Pharmacy, University of Gadjah Mada, Yogyakarta, Indonesia
2 Faculty of Pharmacy, University of Muhammadiyah Purwokerto, Purwokerto, Indonesia
* Corresponding email: endarti_apt@ugm.ac.id
The cost-effectiveness of human papillomavirus (HPV) vaccine for non-cervical cancer including anogenital cancers and head and neck cancers has been evaluated in many countries. This is important for the decision-makers in health policy as they have a limited budget for an enormous option of health technology. The objective of this study is to systematically review the health economic studies in order to evaluate the cost-effectiveness of HPV vaccination for preventing non-cervical cancer including anogenital cancer and head and neck cancer. Approximately 496 articles were obtained from three databases (ProQuest: 430, Scopus: 40 and Pubmed: 29). The screening and selection of the literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The final articles were assessed by using the Consolidated Health Economics Evaluation Reporting Standards (CHEERS) checklist. Based on the review of fifteen articles, most articles concluded that HPV vaccination was cost-effective compared with current standard care. One study showed that HPV vaccination may be cost-effective if only the price is lowered. HPV vaccination is considerably a cost-effective solution to prevent non-cervical cancer based on the studies conducted in many countries particularly the ones with high income.
Key words: cost-effective / human papillomavirus / vaccine / non-cervical cancer / modeling
Note to the reader: The PDF has been updated due to out-of-frame tables, on December 19, 2023.
© The Authors, published by EDP Sciences, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.